Keio University Hospital ( Site 1636)

Shinjyuku, Tokyo 160-8582

1 studies enrolling now · 1 studies all time

What they study most

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) — Recruiting now